Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

View/Open

4003417.pdf (59.83Kb)

Author

Siegel, D S

Richardson, P

Dimopoulos, M

Moreau, P

Mitsiades, C

Weber, D

Houp, J

Gause, C

Vuocolo, S

Eid, J

Graef, T

Anderson, K C

Note: Order does not necessarily reflect citation order of authors.

Published Version

https://doi.org/10.1038/bcj.2014.23

Metadata

Show full item record

Citation

Siegel, D. S., P. Richardson, M. Dimopoulos, P. Moreau, C. Mitsiades, D. Weber, J. Houp, et al. 2014. “Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.” Blood Cancer Journal 4 (4): e202. doi:10.1038/bcj.2014.23. http://dx.doi.org/10.1038/bcj.2014.23.

Other Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003417/pdf/

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA

Citable link to this page

http://nrs.harvard.edu/urn-3:HUL.InstRepos:12153006